Clinical Trial Update: Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial compared imaging-based therapy to risk-factor-based therapy for plaque regression in atherosclerosis and hypercholesterolemia, with c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Hypercholesterolemia

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Atherosclerosis, Hypercholesterolemia | Phase 4 | Status: COMPLETED | Results posted: 2018-10-31